Key Takeaways
- Backlog hits a record, but the mix is shifting: Order backlog reached an all-time high of INR 2,205 crores, up 27% YoY, yet half of new orders now come from non-traditional sectors like nuclear and defense, a deliberate pivot away from a mature chemical glass-lined core.
- Restructuring is a drag now, a tailwind later: A INR 44 crore provision for German workforce reduction and a INR 13 crore Indian labor code provision hit this quarter, but management expects the cost savings to help lift EBITDA margins back toward a 16-18% target.
- The core glass-lined business is being managed for costs, not growth: Management explicitly stated the mature glass-lined market is about cost-cutting, evidenced by closing UK and Hyderabad facilities and downsizing in Germany, while growth capital flows to heavy engineering and mixing.
- Diversification is the entire strategy: With 50% of the order book now from heavy engineering and systems, management is reorganizing business lines and promises investors will see a "different company" in the next few years, though it declined to provide segment-level disclosures to prove it.
- What to watch next quarter: Whether the strong Q4 revenue and order intake momentum materializes as promised, any concrete FY27 guidance, and the pace of margin recovery as German restructuring savings begin to phase in.
Order Intake & Backlog: The Diversification Engine
- Record backlog provides visibility: The INR 2,205 crore backlog is the highest ever, driven by a 20% YoY jump in Q3 order intake to INR 961 crores, putting the company in a stronger position for the next financial year.
- Non-traditional sectors now dominate: For the first time, management disclosed that 50% of order intake and backlog comes from non-chemical, non-pharma industries, a structural shift led by heavy engineering and systems.
- Heavy engineering wins are large and lumpy: The quarter included a ~$30 million defense order and a ~$15 million nuclear order from the Nuclear Power Corporation of India for ancillary equipment like pressure vessels and heat exchangers.
- The mix shift changes revenue conversion: Management cautioned that the 27% backlog increase will not directly convert to 27% revenue growth, as the systems business has a different, longer conversion cycle than traditional product orders.
- Without these large orders, the year looks very different: Per management, if the large non-traditional orders had not materialized, revenue would have been 30% lower for the year, highlighting both the success of the pivot and the dependency it creates.
Tarak Patel: "And for a manufacturing company like us, that is really the name of the game. That is the most important part of our business."
Margin Profile: Restructuring Now for a 16-18% Target Later
- Quarterly margins are noisy by design: Gross margin fell to ~60.1% from ~63% in the prior two quarters due to business mix, while nine-month EBITDA margin trended upward from 12% to 12.7%, which management insists is the fairer view for a long-cycle engineering company.
- Two one-off provisions weighed on the quarter: A INR 44 crore provision was taken for the German workforce reduction agreement, and a separate INR 13 crore provision was booked for India's new labor code implementation.
- Underperforming units are the margin anchor: Pfaudler GmbH in Germany, Switzerland, and China are all delivering below-average EBITDA margins, with Germany being partly loss-making, while newer investments are already trading at higher margins.
- The margin recovery path is gradual, not dramatic: Cost-saving initiatives are in motion, but management stated improvement will come "constantly" rather than in a step-change, with the mid-term target to return to a 16-18% EBITDA margin range.
- A mix shift toward higher-margin businesses helps: The sealing and mixing businesses already trade at significantly above-average margins and are expected to grow faster, mechanically lifting the group margin as their share of revenue increases.
Alexander Poempner: "I think what we gave and we definitely stick to this as a mid-term EBITDA margin to go back to the 16% to 18% range and we are getting there because especially the latest investments, we already achieved better EBITDA margins."
Global Capacity Rationalization: Cutting the Glass-Lined Footprint
- Too much glass-lined capacity globally forced action: The UK facility, over 100 years old, was completely downsized with no glass-lined production remaining; India consolidated from two factories into one running at 80%+ utilization; the Hyderabad facility was sold with land proceeds of INR 55 crores expected this month.
- Germany restructuring is the largest cost lever: An agreement with the Works Council will reduce headcount by roughly 35 people, nearly 30% of the wage bill, with metal fabrication moving to lower-cost countries. Phase-I savings of INR 15-17 crores will hit FY27, with total savings expected above INR 40 crores once fully phased.
- Poland becomes a low-cost manufacturing hub: A new facility started production 3-4 months ago, with ~80% of its output serving Swiss and French subsidiaries that are already booked out, and plans are in place to invest in another facility for stainless-steel or Hastelloy vessels.
- The glass-lined strategy is now explicitly about cost, not growth: Management called it a mature business where the play is to cut costs, not grow market share, a stark framing that signals where capital and attention will not flow.
Tarak Patel: "I know it is not fun to restructure. We would love to have business that was growing and orders coming in, and we could have these factories completely full, but unfortunately, that is not the case."
Heavy Engineering & Systems: The Growth Bet
- A premium player is being built in heavy engineering: The company is now approved by government entities, EIL, and large multinationals, and is pushing up the value chain with a material mix shift from 90% carbon steel three years ago to 60% stainless steel, Hastelloy, and Titanium today.
- Nuclear and defense are real, not aspirational: Large orders from Nuclear Power Corporation of India and a close to $30 million defense order demonstrate the company is already winning in sectors with multi-year investment visibility, particularly as India's nuclear investment program is already approved.
- Capacity exists for near-term growth: The current heavy engineering site can support revenue of INR 600-700 crores without significant new investment, and space is available to expand toward INR 1,000 crores within the existing footprint over the next two to three years.
- Export ambitions are taking shape: Management is targeting the Middle East, Southeast Asia, and Saudi Arabia for heavy engineering exports, while also looking at the US market from India as American demand recovers.
- Edlon gets a dedicated growth investment: A new site is being set up for Edlon, driven by expected significant growth from the semiconductor business and tailwinds from the US Inflation Reduction Act, adding to a high-profitability segment.
End-Market Geography: A Patchy Global Picture
- India is the bright spot, driven by non-chemical investment: Pharma, oil and gas, and nuclear are driving Indian demand, while chemicals remain weak due to overcapacity; Q4 is expected to be a strong quarter for Indian revenue and shipments.
- Europe is slow and uncertain in traditional markets: Chemical and pharma demand remains weak, though defense spending is driving systems business order intake in Europe, and a once-in-a-generation Roche investment in Switzerland sits in the filtration pipeline.
- The Americas are recovering: The US is coming back, South America is seeing growth driven by metals and minerals, rare earths, and oil and gas through SEMCO and MixPro, and services growth has improved in the US market.
- China remains a problem without a clear solution: The China mixing unit is small with order intake behind expectations, and management stated its China strategy is something to "figure out over the next few months," with no immediate resolution in sight.
- An India-EU trade deal could unlock chemical investment: Management noted that chemicals can now be imported into Europe from India, which could drive investment in Indian chemical manufacturing and create more business, though pharma collaboration impacts are too early to call.
Business Reorganization & Disclosure: A Promise, Not Yet a Proof Point
- A structural reorganization is underway: Management is reorganizing business lines to meet specific vertical needs, with each vertical set to have a different strategy, and plans to present this to the board with next year's budget shortly.
- An Analyst Day is ready but on hold: The plan, ideas, numbers, and strategies are prepared, but management is waiting for the market to stabilize before presenting to investors, leaving the reorganization story largely untold for now.
- Segment-level disclosure was explicitly declined: When asked to break out technologies like industrial mixing, GLE, and lab and process glasses to build investor confidence, management declined, saying it will articulate the long-term strategy "at some point" but did not commit to the requested granularity.
- FY27 guidance was also declined: Management would not provide growth rate guidance for FY27, stating it may give broad-level guidance "maybe in the next quarter" after seeing the starting backlog and order intake.
Tarak Patel: "You will see a different company in the next few years. We have already reorganized. We are in the process of reorganizing our business lines to meet specific needs."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Q4 performance | Strong quarter in India for revenue and shipment; order intake momentum to continue | Q4 FY26 |
| Mid-term EBITDA margin | Return to 16% to 18% range, with improvement starting next financial year | Mid-term (full achievement depends on global economy) |
| Germany restructuring savings | Phase-I savings of INR 15-17 crores full year in FY27; total savings above INR 40 crores when fully phased | FY27 and beyond |
| Heavy engineering capacity | Reach INR 600-700 crores revenue from current site without significant new investment | Next 2-3 years |
| Poland expansion | Invest in another facility to increase manufacturing footprint for stainless-steel or Hastelloy vessels | No date given |
| Edlon growth investment | New site set up to capture significant growth from semiconductor business driven by Inflation Reduction Act | Underway |
| FY27 guidance | Broad-level guidance possibly provided | Next quarter (Q4 FY26) |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Revenue (9M FY26) | Up 8% YoY |
| EBITDA (9M FY26) | Up 14% YoY |
| EBITDA margin (9M FY26) | 12.7%, up from 12.0% in 9M FY25 |
| EBITDA margin (Q3 FY26, consol) | 12.7%, flattish versus 12% YoY |
| Gross margin (Q3 FY26) | ~60.1%, compared to ~63% in the previous two quarters |
| Mid-term EBITDA margin target | 16% to 18% range |
| Order intake (Q3 FY26) | ₹961 cr, up 9% QoQ and 20% YoY |
| Order intake (9M FY26) | Up about 16% YoY |
| Order intake from non-traditional industries (9M FY26) | 50% of order intake and corresponding backlog |
| Order backlog | ₹2,205 cr, highest ever, 27% higher than previous year |
| Order backlog split | India: ₹550 cr, International: ₹1,600 cr |
| India order intake (Q3 FY26) | ~₹290 cr |
| International order intake (Q3 FY26) | ~₹600 cr |
| Large defense order | Close to $30 million |
| Large nuclear order | Close to $15 million |
| Exceptional item: Germany cost-reduction program | ₹44 cr impact in Q3 |
| Exceptional item: new labor code in India | ₹13 cr impact in Q3 |
| Germany restructuring: expected full-year savings | Above ₹40 cr over two years, Phase-I savings of ₹15-17 cr in FY27 |
| Germany restructuring: workforce reduction | 35 people, nearly 30% of total wage bill |
| Hyderabad land sale proceeds | ₹55 cr, to be received this month |
| Edlon business size | $25 million, grown about 3x from $8-9 million |
| Heavy engineering capacity | Can hit ₹600-700 cr from current site |
| Services revenue (9M FY26) | ₹800 cr consolidated, 14% growth (per management) |
| Technologies revenue (9M FY26) | ₹950 cr, up from ₹884 cr in 9M FY25 |
| Systems business large order (announced June 2025) | ₹330 cr (€33 million) |